TBIQYR5156-Global Overactive Bladder Treatment Market Research Report 2019
- TBI152746
- February 11, 2019
- Global
- 99 pages
- QY Market Research
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.
Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.
The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.
The global Overactive Bladder Treatment market is valued at 4710 million US$ in 2018 is expected to reach 7230 million US$ by the end of 2025, growing at a CAGR of 5.5% during 2019-2025.
This report focuses on Overactive Bladder Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Overactive Bladder Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Anticholinergics
Mirabegron
Botox
Segment by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Table of Contents
Executive Summary
1 Overactive Bladder Treatment Market Overview
1.1 Product Overview and Scope of Overactive Bladder Treatment
1.2 Overactive Bladder Treatment Segment by Type
1.2.1 Global Overactive Bladder Treatment Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Anticholinergics
1.2.3 Mirabegron
1.2.4 Botox
1.3 Overactive Bladder Treatment Segment by Application
1.3.1 Overactive Bladder Treatment Consumption Comparison by Application (2014-2025)
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.3 Global Overactive Bladder Treatment Market by Region
1.3.1 Global Overactive Bladder Treatment Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Overactive Bladder Treatment Market Size
1.4.1 Global Overactive Bladder Treatment Revenue (2014-2025)
1.4.2 Global Overactive Bladder Treatment Production (2014-2025)
2 Global Overactive Bladder Treatment Market Competition by Manufacturers
2.1 Global Overactive Bladder Treatment Production Market Share by Manufacturers (2014-2019)
2.2 Global Overactive Bladder Treatment Revenue Share by Manufacturers (2014-2019)
2.3 Global Overactive Bladder Treatment Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Overactive Bladder Treatment Production Sites, Area Served, Product Types
2.5 Overactive Bladder Treatment Market Competitive Situation and Trends
2.5.1 Overactive Bladder Treatment Market Concentration Rate
2.5.2 Overactive Bladder Treatment Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Overactive Bladder Treatment Production Market Share by Regions
3.1 Global Overactive Bladder Treatment Production Market Share by Regions
3.2 Global Overactive Bladder Treatment Revenue Market Share by Regions (2014-2019)
3.3 Global Overactive Bladder Treatment Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Overactive Bladder Treatment Production
...
| read more...
Related Reports
TBIQYR989-Global Overall Turbochargers Market Research Report 2019
Published : 04, February
Published : 04, February